Target intelligence / Profile preview

Gastrointestinal tract regulation

01

Overview

Gastrointestinal tract regulation refers to the complex physiological processes that coordinate the movement, secretion, digestion, and absorption within the digestive system (StatPearls, 2023). This regulation is mediated by the enteric nervous system, the autonomic nervous system, and a wide array of hormones and neurotransmitters (NIH, 2023). Key components include the control of gastric emptying, intestinal motility, and the release of digestive enzymes and bile (Britannica, 2024). While many drugs target specific receptors within this system—such as serotonin receptors, opioid receptors, and muscarinic receptors—to treat disorders like irritable bowel syndrome or chronic constipation, "Gastrointestinal tract regulation" itself is a broad physiological category rather than a single druggable molecular target (PubMed, 2022). Consequently, it encompasses various signaling pathways and cellular mechanisms rather than representing a discrete protein or gene product. The regulation involves both local reflexes within the gut wall and long reflexes involving the central nervous system (StatPearls, 2023). Hormonal control is primarily managed by specialized enteroendocrine cells that sense luminal contents and release signaling molecules (NIH, 2023). Dysregulation of these processes can lead to a variety of clinical conditions, including functional dyspepsia and motility disorders (PubMed, 2022).

Other names
GI regulationDigestive system regulationGastrointestinal motility and secretion control
02

Mechanism of action

Not applicable as this is a physiological process, not a discrete molecular target.

03

Biological functions

DigestionGastrointestinal motilityGastric secretionNutrient absorptionFluid and electrolyte balance
04

Disease associations

Irritable bowel syndromeInflammatory bowel diseaseGastroesophageal reflux diseaseGastroparesisChronic constipation
05

Safety considerations

Off-target effects due to systemic distribution of GI-active agentsDisruption of normal gut microbiotaElectrolyte imbalances

Beyond the preview

Go deeper on Gastrointestinal tract regulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastrointestinal tract regulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call